Do oxidative stress, inflammation, nitric oxide impairment, albumin leakage, and homocysteine vulnerability reinforce endothelial dysfunction and plaque instability?

Systemic vascular health relies on a delicate homeostatic balance, which is readily disrupted by several intersecting pathological cascades that converge on the vascular endothelium.

Mechanistic pathways of endothelial injury

• Oxidative and inflammatory stress: Myeloperoxidase (MPO) drives oxidative stress, directly consuming nitric oxide (NO), oxidizing LDL into atherogenic forms, and impairing endothelium-dependent vasodilation. Simultaneously, lipoprotein-associated phospholipase A2 (Lp-PLA2) hydrolyzes oxidized phospholipids in LDL, generating pro-inflammatory lysophosphatidylcholine and oxidized free fatty acids.
• Nitric oxide and methylation disruption: Methylation-related hyperhomocysteinemia elevates levels of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS). This accumulation of ADMA severely limits NO bioavailability, compounding systemic endothelial impairment.
• Albumin leakage as a systemic marker: Generalized endothelial dysfunction increases systemic and glomerular capillary permeability. This structural damage allows albumin to leak across barriers, making microalbuminuria a key clinical surrogate for impaired flow-mediated dilation.

Progression to plaque instability

• Plaque vulnerability: Severe endothelial dysfunction upregulates leukocyte adhesion molecules, increases endothelial permeability to atherogenic lipoproteins, and promotes a pro-thrombotic state. This accelerates lipid-rich necrotic core formation and thin fibrous cap development. Furthermore, Lp-PLA2 activity directly drives necrotic core enlargement and thin cap rupture risk, transforming stable lesions into highly vulnerable plaques.

Bottom line

• Bottom line: Oxidative stress, vascular inflammation, nitric oxide impairment, albumin leakage, and homocysteine vulnerability form a highly synergistic network of vascular injury that reinforces systemic endothelial dysfunction, ultimately driving plaque instability and heightened cardiorenal risk.